Join Us in Tackling Autoimmune Disease at Its Root
At Vor, we believe science can do more than manage symptoms. It can change the course of disease. By advancing telitacicept, a first- and potentially best-in-class dual BAFF/APRIL inhibitor, we are silencing upstream survival signals and stopping downstream autoimmune cascades. Together, we are addressing disease at its root cause and rewriting what is possible for patients worldwide.
When you join Vor, you’re not just working on a medicine. You’re part of a mission to redefine the future of autoimmune care.
Why Work at Vor?
Impact: Contribute directly to a medicine with best-in-disease Phase 3 results in myasthenia gravis and expansion into multiple autoimmune diseases.
Growth: Be part of a rapidly scaling company with opportunities to grow your career in science, clinical development, commercial strategy, and beyond.
Innovation: Work on a platform with potential beyond one indication — a therapy that has already shown consistent results across lupus, IgA nephropathy, and Sjögren’s syndrome.
Belonging: Join a culture where every voice is heard, and where our shared mission unites us across functions and geographies.
Position Summary
The Manager / Senior Manager, Clinical Supply Chain is responsible for the ongoing planning and execution of
global clinical supply strategies supporting two (2) late-stage, pivotal clinical studies. This role ensures
uninterrupted availability of investigational product (IP) across multiple regions Worldwide while maintaining
compliance with GMP, GCP, GDP, and inspection-ready standards. IP is currently PFS-NSD with a migration path to
PFS-AI (autoinjector). The position partners closely with Clinical Operations, Quality, Regulatory Affairs,
Manufacturing, and external CDMOs to manage increased scale, complexity, and regulatory scrutiny typical of
Phase III programs.
Key Responsibilities
Phase III Clinical Supply Strategy & Planning
• Provide clinical supply operational leadership across multiple global clinical studies.
• Foster strong cross-functional partnerships to maintain alignment in planning, supply risk management,
execution, and compliance.
• Coordinate end-to-end logistics for investigational product expiry, labeling, packaging, and distribution to
depots and clinical sites, including temperature excursion management.
• Lead IP label text creation, translation, approval, and printing activities in support of global regulatory
filings, ensuring compliance with local requirements.
• Oversee vendors responsible for outsourced clinical supply activities, ensuring deliverables meet scope,
timeline, and quality standards.
• Forecast and monitor inventory levels and track/manage domestic and international shipments for timely
delivery.
• Coordinate return and destruction of unused or expired investigational product (IP).
• Define Interactive Response Technology (IRT) requirements in collaboration with Clinical Operations and
IRT vendor, and lead/document user acceptance testing (UAT) for IRT systems.
• Collaborate with stakeholders to develop and maintain the Pharmacy Manual and IP training materials for
clinical site personnel.
• Ensure all clinical supply activities are conducted in accordance with SOPs, regulatory standards, and
Quality requirements.
CDMO, Packaging & 3PL Management
• Serve as primary clinical supply chain contact for CDMOs, packaging and labeling vendors, and clinical
logistics providers.
• Coordinate IP manufacturing campaigns and packaging runs aligned with Phase III timelines.
• Monitor vendor performance, capacity, lead times, and risk indicators.
Quality & Inspection Readiness
• Ensure all clinical supply chain activities comply with cGMP, GCP, GDP, and global regulatory
requirements.
• Partner with Quality on batch release, deviations, investigations, CAPAs, and change controls.
• Support regulatory submissions (IND amendments, CTA updates) with supply chain documentation.
Cross-Functional Leadership
• Act as a core member of the Phase III study team, providing supply chain leadership and risk mitigation.
• Partner with Clinical Operations on enrollment forecasting, country strategy, and site activation plans.
• Communicate supply status, risks, and mitigation strategies to senior leadership and governance forums.
Systems, Metrics & Process Optimization
• Own and maintain Phase III clinical supply plans, dashboards, and KPIs.
• Leverage IRT/RTSM systems and planning tools to support resupply and inventory visibility.
• Drive process improvements to improve scalability, compliance, and cost efficiency.
Qualifications/ Experience
• Manager: 4–6 years of clinical supply chain experience in biotech or pharma.
• Senior Manager: 6–8+ years of progressive clinical supply chain experience.
• Direct experience supporting Phase III or late-stage clinical trials.
• Experience with global IP distribution, depots, and Country-specific labeling.
• Strong background working with CDMOs, Packaging vendors, and Clinical 3PLs.
• Experience supporting programs approaching BLA/NDA submission preferred.
Skills & Competencies
• Deep understanding of Phase III clinical supply models and global distribution strategies.
• Strong proficiency in IRT systems, Excel-based forecasting, and planning tools.
• Adept with Excel, pivot tables, data analyses and able to interpret large data sets.
• Use of Smartsheets to create tables, plans, charts and interactive dashboards.
• Strong knowledge of GMP, GCP, GDP, and inspection expectations.
• Advanced planning, scenario modeling, and risk management skills.
• Ability to manage complexity and ambiguity in late-stage programs.
• Excellent cross-functional communication and leadership skills.
Education
• Bachelor’s degree in Supply Chain, Life Sciences, Engineering, or related discipline
• Advanced degree preferred (Senior Manager level).
Leadership Expectations (Senior Manager)
• Own clinical supply strategy for one or more Phase III programs.
• Mentor and develop clinical supply chain team members.
• Influence study and portfolio-level decisions at the Director and VP level.
• Lead inspection readiness and supply chain representation during audits.
The salary range for the Manager Clinical Supply Chain is expected to be between $140,000 and $155,000 per year. Individual pay may vary based on multiple factors including but not limited to relevant job-related skills, experience, education or training, market factors, and work location.
The salary range for the Senior Manager Clinical Supply Chain is expected to be between $170,000 and $180,000 per year. Individual pay may vary based on multiple factors including but not limited to relevant job-related skills, experience, education or training, market factors, and work location.
Why Join Us?
• We are a great team that is growing!
• This is a critical role supporting pivotal trials and regulatory milestones.
• Hands-on and high visibility with strategic impact across the organization.
• Opportunity to be part of the transition from late-stage clinical to commercial readiness.
• We will become the global leader in targeted therapeutics for autoimmune diseases.
At Vor, we support our team with robust benefits, including comprehensive health coverage, flexible paid time off, generous parental leave, and a competitive 401(k). From education assistance to wellness resources and financial security, we invest in your well-being so you can thrive at work and beyond.
As an equal opportunity employer, we at Vor Bio know that diversity inspires innovation, inclusiveness, and creativity. We invite you to come as you are. All applicants will be considered for employment agnostic to race, age, color, religion, sex, sexual orientation, gender identity, national origin, veteran or disability status.
Please visit our website at https://www.vorbio.com/ for more information.
Top Skills
Vor Bio Cambridge, Massachusetts, USA Office
100 Cambridgepark Dr, Suite 101, Cambridge, MA, United States, 02140
Similar Jobs
What you need to know about the Boston Tech Scene
Key Facts About Boston Tech
- Number of Tech Workers: 269,000; 9.4% of overall workforce (2024 CompTIA survey)
- Major Tech Employers: Thermo Fisher Scientific, Toast, Klaviyo, HubSpot, DraftKings
- Key Industries: Artificial intelligence, biotechnology, robotics, software, aerospace
- Funding Landscape: $15.7 billion in venture capital funding in 2024 (Pitchbook)
- Notable Investors: Summit Partners, Volition Capital, Bain Capital Ventures, MassVentures, Highland Capital Partners
- Research Centers and Universities: MIT, Harvard University, Boston College, Tufts University, Boston University, Northeastern University, Smithsonian Astrophysical Observatory, National Bureau of Economic Research, Broad Institute, Lowell Center for Space Science & Technology, National Emerging Infectious Diseases Laboratories
